Report Detail
COVID-19 Impact on Global Biologics Drug Discovery Market Size, Status and Forecast 2020-2026
- RnM3985184 |
- 03 June, 2020 |
- Global |
- 132 Pages |
- QYResearch |
- Other
The biologics drug discovery involves target identification, hit-to-lead stage, lead identification and optimization.
Since the COVID-19 virus outbreak in December 2019, the disease has spread to almost 100 countries around the globe with the World Health Organization declaring it a public health emergency. The global impacts of the coronavirus disease 2019 (COVID-19) are already starting to be felt, and will significantly affect the Biologics Drug Discovery market in 2020.
COVID-19 can affect the global economy in three main ways: by directly affecting production and demand, by creating supply chain and market disruption, and by its financial impact on firms and financial markets.
The outbreak of COVID-19 has brought effects on many aspects, like flight cancellations; travel bans and quarantines; restaurants closed; all indoor events restricted; over forty countries state of emergency declared; massive slowing of the supply chain; stock market volatility; falling business confidence, growing panic among the population, and uncertainty about future.
This report also analyses the impact of Coronavirus COVID-19 on the Biologics Drug Discovery industry.
Based on our recent survey, we have several different scenarios about the Biologics Drug Discovery YoY growth rate for 2020. The probable scenario is expected to grow by a xx% in 2020 and the revenue will be xx in 2020 from US$ xx million in 2019. The market size of Biologics Drug Discovery will reach xx in 2026, with a CAGR of xx% from 2020 to 2026.
With industry-standard accuracy in analysis and high data integrity, the report makes a brilliant attempt to unveil key opportunities available in the global Biologics Drug Discovery market to help players in achieving a strong market position. Buyers of the report can access verified and reliable market forecasts, including those for the overall size of the global Biologics Drug Discovery market in terms of revenue.
Players, stakeholders, and other participants in the global Biologics Drug Discovery market will be able to gain the upper hand as they use the report as a powerful resource. For this version of the report, the segmental analysis focuses on revenue and forecast by each application segment in terms of revenue and forecast by each type segment in terms of revenue for the period 2015-2026.
Regional and Country-level Analysis
The report offers an exhaustive geographical analysis of the global Biologics Drug Discovery market, covering important regions, viz, North America, Europe, China, Japan, Southeast Asia, India and Central & South America. It also covers key countries (regions), viz, U.S., Canada, Germany, France, U.K., Italy, Russia, China, Japan, South Korea, India, Australia, Taiwan, Indonesia, Thailand, Malaysia, Philippines, Vietnam, Mexico, Brazil, Turkey, Saudi Arabia, U.A.E, etc.
The report includes country-wise and region-wise market size for the period 2015-2026. It also includes market size and forecast by each application segment in terms of revenue for the period 2015-2026.
Competition Analysis
In the competitive analysis section of the report, leading as well as prominent players of the global Biologics Drug Discovery market are broadly studied on the basis of key factors. The report offers comprehensive analysis and accurate statistics on revenue by the player for the period 2015-2020. It also offers detailed analysis supported by reliable statistics on price and revenue (global level) by player for the period 2015-2020.
On the whole, the report proves to be an effective tool that players can use to gain a competitive edge over their competitors and ensure lasting success in the global Biologics Drug Discovery market. All of the findings, data, and information provided in the report are validated and revalidated with the help of trustworthy sources. The analysts who have authored the report took a unique and industry-best research and analysis approach for an in-depth study of the global Biologics Drug Discovery market.
The following players are covered in this report:
GenScript
Roche
Pfizer
Novartis
Sanofi
Merck
GlaxoSmithKline
AstraZeneca
AbbVie
Amgen
Bristol-Myers Squibb
Novo Nordisk
Allergan
Astellas Pharma
Teva Pharmaceutical Industries
Biologics Drug Discovery Breakdown Data by Type
Biologicals
Monoclonal Antibodies
Recombinant Proteins
Other Biologics
Biologics Drug Discovery Breakdown Data by Application
Hospitals
Clinics
Research Labs
Diagnostic Centers
Others
1 Report Overview
- 1.1 Study Scope
- 1.2 Key Market Segments
- 1.3 Players Covered: Ranking by Biologics Drug Discovery Revenue
- 1.4 Market Analysis by Type
- 1.4.1 Global Biologics Drug Discovery Market Size Growth Rate by Type: 2020 VS 2026
- 1.4.2 Biologicals
- 1.4.3 Monoclonal Antibodies
- 1.4.4 Recombinant Proteins
- 1.4.5 Other Biologics
- 1.5 Market by Application
- 1.5.1 Global Biologics Drug Discovery Market Share by Application: 2020 VS 2026
- 1.5.2 Hospitals
- 1.5.3 Clinics
- 1.5.4 Research Labs
- 1.5.5 Diagnostic Centers
- 1.5.6 Others
- 1.6 Coronavirus Disease 2019 (Covid-19): Biologics Drug Discovery Industry Impact
- 1.6.1 How the Covid-19 is Affecting the Biologics Drug Discovery Industry
- 1.6.1.1 Biologics Drug Discovery Business Impact Assessment - Covid-19
- 1.6.1.2 Supply Chain Challenges
- 1.6.1.3 COVID-19’s Impact On Crude Oil and Refined Products
- 1.6.2 Market Trends and Biologics Drug Discovery Potential Opportunities in the COVID-19 Landscape
- 1.6.3 Measures / Proposal against Covid-19
- 1.6.3.1 Government Measures to Combat Covid-19 Impact
- 1.6.3.2 Proposal for Biologics Drug Discovery Players to Combat Covid-19 Impact
- 1.6.1 How the Covid-19 is Affecting the Biologics Drug Discovery Industry
- 1.7 Study Objectives
- 1.8 Years Considered
2 Global Growth Trends by Regions
- 2.1 Biologics Drug Discovery Market Perspective (2015-2026)
- 2.2 Biologics Drug Discovery Growth Trends by Regions
- 2.2.1 Biologics Drug Discovery Market Size by Regions: 2015 VS 2020 VS 2026
- 2.2.2 Biologics Drug Discovery Historic Market Share by Regions (2015-2020)
- 2.2.3 Biologics Drug Discovery Forecasted Market Size by Regions (2021-2026)
- 2.3 Industry Trends and Growth Strategy
- 2.3.1 Market Top Trends
- 2.3.2 Market Drivers
- 2.3.3 Market Challenges
- 2.3.4 Porter’s Five Forces Analysis
- 2.3.5 Biologics Drug Discovery Market Growth Strategy
- 2.3.6 Primary Interviews with Key Biologics Drug Discovery Players (Opinion Leaders)
3 Competition Landscape by Key Players
- 3.1 Global Top Biologics Drug Discovery Players by Market Size
- 3.1.1 Global Top Biologics Drug Discovery Players by Revenue (2015-2020)
- 3.1.2 Global Biologics Drug Discovery Revenue Market Share by Players (2015-2020)
- 3.1.3 Global Biologics Drug Discovery Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
- 3.2 Global Biologics Drug Discovery Market Concentration Ratio
- 3.2.1 Global Biologics Drug Discovery Market Concentration Ratio (CR5 and HHI)
- 3.2.2 Global Top 10 and Top 5 Companies by Biologics Drug Discovery Revenue in 2019
- 3.3 Biologics Drug Discovery Key Players Head office and Area Served
- 3.4 Key Players Biologics Drug Discovery Product Solution and Service
- 3.5 Date of Enter into Biologics Drug Discovery Market
- 3.6 Mergers & Acquisitions, Expansion Plans
4 Breakdown Data by Type (2015-2026)
- 4.1 Global Biologics Drug Discovery Historic Market Size by Type (2015-2020)
- 4.2 Global Biologics Drug Discovery Forecasted Market Size by Type (2021-2026)
5 Biologics Drug Discovery Breakdown Data by Application (2015-2026)
- 5.1 Global Biologics Drug Discovery Market Size by Application (2015-2020)
- 5.2 Global Biologics Drug Discovery Forecasted Market Size by Application (2021-2026)
6 North America
- 6.1 North America Biologics Drug Discovery Market Size (2015-2020)
- 6.2 Biologics Drug Discovery Key Players in North America (2019-2020)
- 6.3 North America Biologics Drug Discovery Market Size by Type (2015-2020)
- 6.4 North America Biologics Drug Discovery Market Size by Application (2015-2020)
7 Europe
- 7.1 Europe Biologics Drug Discovery Market Size (2015-2020)
- 7.2 Biologics Drug Discovery Key Players in Europe (2019-2020)
- 7.3 Europe Biologics Drug Discovery Market Size by Type (2015-2020)
- 7.4 Europe Biologics Drug Discovery Market Size by Application (2015-2020)
8 China
- 8.1 China Biologics Drug Discovery Market Size (2015-2020)
- 8.2 Biologics Drug Discovery Key Players in China (2019-2020)
- 8.3 China Biologics Drug Discovery Market Size by Type (2015-2020)
- 8.4 China Biologics Drug Discovery Market Size by Application (2015-2020)
9 Japan
- 9.1 Japan Biologics Drug Discovery Market Size (2015-2020)
- 9.2 Biologics Drug Discovery Key Players in Japan (2019-2020)
- 9.3 Japan Biologics Drug Discovery Market Size by Type (2015-2020)
- 9.4 Japan Biologics Drug Discovery Market Size by Application (2015-2020)
10 Southeast Asia
- 10.1 Southeast Asia Biologics Drug Discovery Market Size (2015-2020)
- 10.2 Biologics Drug Discovery Key Players in Southeast Asia (2019-2020)
- 10.3 Southeast Asia Biologics Drug Discovery Market Size by Type (2015-2020)
- 10.4 Southeast Asia Biologics Drug Discovery Market Size by Application (2015-2020)
11 India
- 11.1 India Biologics Drug Discovery Market Size (2015-2020)
- 11.2 Biologics Drug Discovery Key Players in India (2019-2020)
- 11.3 India Biologics Drug Discovery Market Size by Type (2015-2020)
- 11.4 India Biologics Drug Discovery Market Size by Application (2015-2020)
12 Central & South America
- 12.1 Central & South America Biologics Drug Discovery Market Size (2015-2020)
- 12.2 Biologics Drug Discovery Key Players in Central & South America (2019-2020)
- 12.3 Central & South America Biologics Drug Discovery Market Size by Type (2015-2020)
- 12.4 Central & South America Biologics Drug Discovery Market Size by Application (2015-2020)
13 Key Players Profiles
- 13.1 GenScript
- 13.1.1 GenScript Company Details
- 13.1.2 GenScript Business Overview and Its Total Revenue
- 13.1.3 GenScript Biologics Drug Discovery Introduction
- 13.1.4 GenScript Revenue in Biologics Drug Discovery Business (2015-2020))
- 13.1.5 GenScript Recent Development
- 13.2 Roche
- 13.2.1 Roche Company Details
- 13.2.2 Roche Business Overview and Its Total Revenue
- 13.2.3 Roche Biologics Drug Discovery Introduction
- 13.2.4 Roche Revenue in Biologics Drug Discovery Business (2015-2020)
- 13.2.5 Roche Recent Development
- 13.3 Pfizer
- 13.3.1 Pfizer Company Details
- 13.3.2 Pfizer Business Overview and Its Total Revenue
- 13.3.3 Pfizer Biologics Drug Discovery Introduction
- 13.3.4 Pfizer Revenue in Biologics Drug Discovery Business (2015-2020)
- 13.3.5 Pfizer Recent Development
- 13.4 Novartis
- 13.4.1 Novartis Company Details
- 13.4.2 Novartis Business Overview and Its Total Revenue
- 13.4.3 Novartis Biologics Drug Discovery Introduction
- 13.4.4 Novartis Revenue in Biologics Drug Discovery Business (2015-2020)
- 13.4.5 Novartis Recent Development
- 13.5 Sanofi
- 13.5.1 Sanofi Company Details
- 13.5.2 Sanofi Business Overview and Its Total Revenue
- 13.5.3 Sanofi Biologics Drug Discovery Introduction
- 13.5.4 Sanofi Revenue in Biologics Drug Discovery Business (2015-2020)
- 13.5.5 Sanofi Recent Development
- 13.6 Merck
- 13.6.1 Merck Company Details
- 13.6.2 Merck Business Overview and Its Total Revenue
- 13.6.3 Merck Biologics Drug Discovery Introduction
- 13.6.4 Merck Revenue in Biologics Drug Discovery Business (2015-2020)
- 13.6.5 Merck Recent Development
- 13.7 GlaxoSmithKline
- 13.7.1 GlaxoSmithKline Company Details
- 13.7.2 GlaxoSmithKline Business Overview and Its Total Revenue
- 13.7.3 GlaxoSmithKline Biologics Drug Discovery Introduction
- 13.7.4 GlaxoSmithKline Revenue in Biologics Drug Discovery Business (2015-2020)
- 13.7.5 GlaxoSmithKline Recent Development
- 13.8 AstraZeneca
- 13.8.1 AstraZeneca Company Details
- 13.8.2 AstraZeneca Business Overview and Its Total Revenue
- 13.8.3 AstraZeneca Biologics Drug Discovery Introduction
- 13.8.4 AstraZeneca Revenue in Biologics Drug Discovery Business (2015-2020)
- 13.8.5 AstraZeneca Recent Development
- 13.9 AbbVie
- 13.9.1 AbbVie Company Details
- 13.9.2 AbbVie Business Overview and Its Total Revenue
- 13.9.3 AbbVie Biologics Drug Discovery Introduction
- 13.9.4 AbbVie Revenue in Biologics Drug Discovery Business (2015-2020)
- 13.9.5 AbbVie Recent Development
- 13.10 Amgen
- 13.10.1 Amgen Company Details
- 13.10.2 Amgen Business Overview and Its Total Revenue
- 13.10.3 Amgen Biologics Drug Discovery Introduction
- 13.10.4 Amgen Revenue in Biologics Drug Discovery Business (2015-2020)
- 13.10.5 Amgen Recent Development
- 13.11 Bristol-Myers Squibb
- 10.11.1 Bristol-Myers Squibb Company Details
- 10.11.2 Bristol-Myers Squibb Business Overview and Its Total Revenue
- 10.11.3 Bristol-Myers Squibb Biologics Drug Discovery Introduction
- 10.11.4 Bristol-Myers Squibb Revenue in Biologics Drug Discovery Business (2015-2020)
- 10.11.5 Bristol-Myers Squibb Recent Development
- 13.12 Novo Nordisk
- 10.12.1 Novo Nordisk Company Details
- 10.12.2 Novo Nordisk Business Overview and Its Total Revenue
- 10.12.3 Novo Nordisk Biologics Drug Discovery Introduction
- 10.12.4 Novo Nordisk Revenue in Biologics Drug Discovery Business (2015-2020)
- 10.12.5 Novo Nordisk Recent Development
- 13.13 Allergan
- 10.13.1 Allergan Company Details
- 10.13.2 Allergan Business Overview and Its Total Revenue
- 10.13.3 Allergan Biologics Drug Discovery Introduction
- 10.13.4 Allergan Revenue in Biologics Drug Discovery Business (2015-2020)
- 10.13.5 Allergan Recent Development
- 13.14 Astellas Pharma
- 10.14.1 Astellas Pharma Company Details
- 10.14.2 Astellas Pharma Business Overview and Its Total Revenue
- 10.14.3 Astellas Pharma Biologics Drug Discovery Introduction
- 10.14.4 Astellas Pharma Revenue in Biologics Drug Discovery Business (2015-2020)
- 10.14.5 Astellas Pharma Recent Development
- 13.15 Teva Pharmaceutical Industries
- 10.15.1 Teva Pharmaceutical Industries Company Details
- 10.15.2 Teva Pharmaceutical Industries Business Overview and Its Total Revenue
- 10.15.3 Teva Pharmaceutical Industries Biologics Drug Discovery Introduction
- 10.15.4 Teva Pharmaceutical Industries Revenue in Biologics Drug Discovery Business (2015-2020)
- 10.15.5 Teva Pharmaceutical Industries Recent Development
14 Analyst's Viewpoints/Conclusions
15 Appendix
- 15.1 Research Methodology
- 15.1.1 Methodology/Research Approach
- 15.1.2 Data Source
- 15.2 Disclaimer
Summary:
Get latest Market Research Reports on COVID-19 Impact on Global Biologics Drug Discovery. Industry analysis & Market Report on COVID-19 Impact on Global Biologics Drug Discovery is a syndicated market report, published as COVID-19 Impact on Global Biologics Drug Discovery Market Size, Status and Forecast 2020-2026. It is complete Research Study and Industry Analysis of COVID-19 Impact on Global Biologics Drug Discovery market, to understand, Market Demand, Growth, trends analysis and Factor Influencing market.
REPORT YOU MIGHT BE INTERESTED
Related Reports
Reason to Buy
Reports and Markets
Contact Us
+1-352-353-0818 (US)Newsletter
KEEP UP TO DATE ON ALL THE LATEST REPORTS
